|4Oct 5, 6:39 PM ET

FROM STEPHEN 4

4 · EYEGATE PHARMACEUTICALS INC · Filed Oct 5, 2021

Insider Transaction Report

Form 4
Period: 2021-10-04
FROM STEPHEN
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2021-10-04$2.01/sh249$50068,542 total
Footnotes (1)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021.

Documents

1 file
  • 4
    tm2129310d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT